Part 1- Background Information
Ch 1-1: The Purpose of This Handbook
Ch 1-2: Your Mission on the IRB
Ch 1-3: A Brief History of the IRB System
Ch 1-4: Principles of the Belmont Report
Part 2- The Full Committee IRB Meeting
Ch 2-1: The Work Before An IRB Meeting
Ch 2-2: Reviewing A New Research Proposal
Ch 2-3: The Consent Document
Ch 2-4: Continuing Review of Research
Ch 2-5: Protocol Revisions (Amendments)
Ch 2-6: Adverse Event Reports
Ch 2-7: Primary Reviewer Presentations
Part 3- Specific Topics
Ch 3-1: Evaluating Study Design and Quality
Ch 3-2: Researcher Conflict of Interest
Ch 3-3: Advertisements for Research
Ch 3-4: Denying Subjects Access to Research Results
Ch 3-5: Paying Research Subjects
Ch 3-6: Deception of Research Subjects
Ch 3-7: Qualitative Social Science Research
Ch 3-8: Research Without Informed Consent or Documentation
Ch 3-9: When are Research Risks Reasonable in Relationship To Anticipated Benefits?
Ch 3-10: Exculpatory Language in the Consent Document
Ch 3-11
Ch 3-12: Vulnerability in Research
Ch 3-13: Placebo-Controlled Trials
Ch 3-14: Treatment Withholding and Washout Periods
Ch 3-15: Phase 1 Oncology Trials
Ch 3-16: Research Involving Prisoners
Ch 3-17: Research Involving Children
Ch 3-18: HIPAA
Part 4: Resources for Additional Information
Ch 4-1: Ethical Codes
Ch 4-2: U.S. Government Regulations
Ch 4-3: U.S. Government Guidance/Resources
Ch 4-4: International Guidelines
Ch 4-5: Books
Ch 4-6: Periodicals and the IRB Form
Ch 4-7: Video Recordings
Ch 4-8: Organizations